Eland Siddle, Pharm.D., is co-founder and CEO of Luvo Health, where he sets the company's strategy and leads its mission to make longevity care accessible to everyone, not just the wealthy.

Eland has built this before. At Lemonaid Health, one of the first national telehealth companies, he built and led the pharmacy serving patients in all 50 states through the company's $400M acquisition by 23andMe. He then spent three years scaling operations at 23andMe, where he led the launch of its GLP-1 weight management program from planning to patients.

He started Luvo because of what he saw next. As demand for GLP-1s, peptides, and hormone therapy exploded, people started turning to sources with no clinical oversight and no pharmacy standards behind them: research-grade products, unlicensed sellers, and companies making promises they couldn't back up. As a pharmacist, he knew what patients couldn't see. Luvo gives them a legitimate place to go, with licensed clinicians, licensed pharmacies, and fair pricing.

Eland also serves as Chief Operating Officer of Fore Genomics, which helps parents identify genetic health risks in their children early.